Literature DB >> 231089

Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice.

S Nagafuchi, H Oda, R Mori, T Taniguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 231089     DOI： 10.1099/0022-1317-44-3-715

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


× No keyword cloud information.
  28 in total

1.  Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model.

Authors:  Subhajit Biswas; Soumi Sukla; Thomas Goldner; Hugh J Field; Dirk Kropeit; Daniela Paulsen; André Welbers; Helga Ruebsamen-Schaeff; Holger Zimmermann; Alexander Birkmann
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

2.  Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Differential susceptibility and resistance of immunocompetent and immunodeficient mice to fatal Hantaan virus infection.

Authors:  T Nakamura; R Yanagihara; C J Gibbs; H L Amyx; D C Gajdusek
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

4.  Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.

Authors:  Adalbert Krawczyk; Jürgen Krauss; Anna M Eis-Hübinger; Martin P Däumer; Robert Schwarzenbacher; Ulf Dittmer; Karl E Schneweis; Dirk Jäger; Michael Roggendorf; Michaela A E Arndt
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

5.  Clinical, pathologic, and immunopathologic characteristics of experimental murine herpes simplex virus stromal keratitis and uveitis is controlled by gene products from the Igh-1 locus on chromosome 12.

Authors:  C S Foster; E M Opremcak; B Rice; P Wells; H Chung; P Thompson; L P Fong; M Raizman
Journal:  Trans Am Ophthalmol Soc       Date:  1987

6.  Murine herpes simplex virus keratitis is accentuated by CD4+, V beta 8.2+ Th2 T cells.

Authors:  C S Foster; A Rodriguez Garcia; M Pedroza-Seres; A Berra; A Heiligenhaus; S Soukiasian; S Jayaraman
Journal:  Trans Am Ophthalmol Soc       Date:  1993

7.  Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease.

Authors:  A Simmons; A A Nash
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

8.  Role of Langerhans cells and Thy. 1+ effector cells in herpes simplex virus-1 infection in the skin of newborn mice.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

9.  Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Authors:  Shin-Ichiro Kawamoto; Kenji Oritani; Hideo Asada; Isao Takahashi; Jun Ishikawa; Hitoshi Yoshida; Masahide Yamada; Naoko Ishida; Hidetoshi Ujiie; Hiroaki Masaie; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice.

Authors:  T Valyi-Nagy; S L Deshmane; B Raengsakulrach; M Nicosia; R M Gesser; M Wysocka; A Dillner; N W Fraser
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.